TriStar Wellness Solutions, Inc. (TWSI) Reports Strong Q1 Sales, Expectations for Continued Growth
TriStar Wellness Solutions® subsidiary HemCon Medical Technologies, a developer and marketer of advanced medical products, reports significant sales growth and momentum for the HemCon hemostatic product line in Japan, with 2014 first-quarter sales exceeding overall sales for the previous year. The company attributes the growth to a new focus on sales and marketing efforts of HemCon's exclusive partner in Japan, Zeria Pharmaceuticals Ltd. Co. (Zeria), who has worked with the HemCon product line since 2010. This collaboration ensures that current and newly developed products become the standard of care for hemostasis in the country. HemCon products and solutions are designed…